Clinical Trials Logo

Stress Hyperglycemia clinical trials

View clinical trials related to Stress Hyperglycemia.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05314725 Not yet recruiting - Clinical trials for Stress Hyperglycemia

Treatment With SGLT-2 Inhibitor for Postoperative Hyperglycemia in Acute Abdominal Surgery - a Randomized Trial

Start date: June 1, 2022
Phase: Phase 2
Study type: Interventional

The aim of the study is to investigate the effect of an SGLT-2 inhibitor on postoperative hyperglycemia after acute abdominal surgery in patients without diabetes

NCT ID: NCT04591561 Not yet recruiting - Clinical trials for Stress Hyperglycemia

Incidence and Course of Stress Hyperglycemia in Critically Ill Children Admitted to PICU of Assiut University Children Hospital

Start date: December 1, 2020
Phase:
Study type: Observational [Patient Registry]

Detection of the prevelance of stress hyperglycemia in patients admitted to pediatric intensive care unit of Assiut university children hospital , asses its pattern ,course ,risk factors, its relation to the outcome and its management.

NCT ID: NCT01776476 Not yet recruiting - Critical Illness Clinical Trials

A Randomized Controlled Trial of Glutamine Dipeptide in Severe Trauma

GLND Trauma
Start date: February 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to find out if giving certain amino acids to critically injured patients can improve their condition or recovery, and lower their blood sugar and insulin needs. Amino acids are the 'building blocks' of proteins. The amino acid compound used in this study is called alanyl-glutamine dipeptide, also known as Dipeptiven® or glutamine. Glutamine is investigational, meaning not approved by the Food and Drug Administration (FDA) for intravenous use. However, it is approved by many countries in Europe, Asia and South America. Several studies suggest that giving glutamine has certain benefits in patients who need intensive care. In a study done at Emory University Medical Center using the same dose of glutamine, the number of hospital infections was lower in patients who had had cardiac, blood vessel or intestinal surgery compared to similar patients who received standard feedings without glutamine. No side effects were thought to be due to giving glutamine in that small study. This study is only being done at Vanderbilt University. The investigators plan to enroll 24 patients in the Trauma ICU over the next 12 months.